---
id: 115
title: Anaerobic Bacteria and Infections
category: organisms
subcategory: anaerobes
tags: [anaerobes, Bacteroides, Clostridium, aspiration, abscess, metronidazole]
difficulty: medium
---

## Question

When should anaerobic coverage be considered? Use the **"Abscess, Aspiration, Below-the-Diaphragm"** framework.

## Answer

### **Clinical Scenarios Requiring Anaerobic Coverage:**

**"3 A's + B" Framework:**
- **Abscess** (brain, lung, intra-abdominal, liver)
- **Aspiration pneumonia** (witnessed aspiration, poor dentition)
- **Abdominal infections** (below-the-diaphragm: intra-abdominal, pelvic)
- **Bite wounds** (human, animal)
- **Necrotizing soft tissue infections**

### **Major Anaerobes:**

| Organism | Site | Infections | Treatment |
|----------|------|------------|-----------|
| ***Bacteroides fragilis*** | **GI tract** | **Intra-abdominal infections**, bacteremia, liver abscess | **Metronidazole 500mg IV q8h** OR **pip-tazo**, **meropenem** |
| ***Clostridium perfringens*** | **GI tract**, soil | **Gas gangrene**, necrotizing fasciitis, food poisoning | **Penicillin G 4 MU IV q4h + clindamycin 900mg IV q8h** + **urgent surgery** |
| ***Clostridium difficile*** | **GI tract** | Colitis, diarrhea | **Vancomycin 125mg PO QID** OR **fidaxomicin** |
| **Fusobacterium necrophorum** | **Oropharynx** | **Lemierre syndrome** (pharyngitis → septic thrombophlebitis of internal jugular vein) | **Metronidazole** OR **pip-tazo** |
| **Peptostreptococcus**, **Prevotella** | **Oropharynx** | Aspiration pneumonia, brain abscess, dental infections | **Ampicillin-sulbactam**, **clindamycin**, **metronidazole** |

### **Anaerobic Coverage by Agent:**

| Antibiotic | *B. fragilis* Coverage | Oral Anaerobes | Notes |
|------------|----------------------|----------------|-------|
| **Metronidazole** | **Excellent** | **Excellent** | **First-line** for anaerobes; NO Gram-positive cocci coverage |
| **Clindamycin** | Good | **Excellent** | **Resistance increasing** in *B. fragilis* (20-30%) |
| **Ampicillin-sulbactam** | Good | Excellent | Good for mixed infections (aerobes + anaerobes) |
| **Piperacillin-tazobactam** | **Excellent** | Excellent | Broad-spectrum (Gram-neg + anaerobes) |
| **Meropenem** | **Excellent** | Excellent | Carbapenem (reserve for ESBL/resistant) |
| **Ceftriaxone** | **POOR** | Poor | **NO anaerobic coverage** |
| **Fluoroquinolones** (cipro, levo) | **POOR** | Poor | **NO anaerobic coverage** (except moxifloxacin) |

### **Clues to Anaerobic Infection:**

- **Foul-smelling discharge/pus**
- **Gas in tissues** (crepitus, gas on imaging)
- **Abscess formation**
- **Necrotic tissue**
- **Gram stain:** Polymicrobial, mixed morphology
- **Fails to grow** on routine aerobic cultures

## Key Points

### **Specific Syndromes:**

**Aspiration Pneumonia:**
- **Witnessed aspiration** + **poor dentition** + **dependent lung segments**
- **Coverage:** Oral anaerobes (Peptostreptococcus, Prevotella, Fusobacterium)
- **Treatment:** Ampicillin-sulbactam OR pip-tazo OR clindamycin

**Brain Abscess:**
- **Often polymicrobial** (anaerobes + *Streptococcus*, *Staphylococcus*)
- **Sources:** Sinusitis, otitis, dental, endocarditis, penetrating trauma
- **Treatment:** Metronidazole + **ceftriaxone** + **vancomycin** (empiric)

**Lemierre Syndrome:**
- ***Fusobacterium necrophorum***
- **Pharyngitis → septic thrombophlebitis of internal jugular vein** → septic emboli (lungs)
- **Treatment:** Metronidazole OR pip-tazo × 2-6 weeks ± anticoagulation (controversial)

**Gas Gangrene (*C. perfringens*):**
- **Rapid onset** after trauma/surgery (myonecrosis)
- **Crepitus, gas in tissues**, bronze skin discoloration
- **Treatment:** **Penicillin G + clindamycin** + **urgent surgical debridement** ± hyperbaric oxygen

### **Clinical Pearls:**
- **Metronidazole** excellent for *B. fragilis* and oral anaerobes
- **Abscess, aspiration, abdominal** = anaerobic coverage
- **Foul-smelling pus** = anaerobes
- **Gas gangrene:** Penicillin G + clindamycin + urgent surgery
- **Lemierre syndrome:** Pharyngitis → IJV thrombosis (*Fusobacterium*)
- **Ceftriaxone/fluoroquinolones have NO anaerobic coverage**

## Sources

- [IDSA: Intra-Abdominal Infections Guidelines 2024]
- [Surgical Infections: Necrotizing Infections 2023]

## Media

N/A
